Bluefin Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,800
Closed -$820 462
2022
Q4
$820 Buy
24,800
+14,800
+148% +$399K ﹤0.01% 452
2022
Q3
$5K Hold
10,000
﹤0.01% 491
2022
Q2
$30K Buy
+10,000
New +$425K ﹤0.01% 441
2022
Q1
Sell
-11,300
Closed -$20K 970
2021
Q4
$20K Buy
+11,300
New +$1.35M ﹤0.01% 760

Other funds holding TDOC

Bluefin Capital Management's TDOC Position: Q2 2021 in Review

Bluefin Capital Management sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,165 shares — an estimated $393K sold.

Bluefin Capital Management first reported a position in TDOC in Q4 2020 and held it in 2 quarters. The position peaked at $393K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Bluefin Capital Management reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Bluefin Capital Management sold 2,165 Teladoc Health shares in Q2 2021, an estimated $393K.
  • Bluefin Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 2 quarters.
  • Bluefin Capital Management's Teladoc Health position peaked at $393K in Q1 2021.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Bluefin Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.